146 related articles for article (PubMed ID: 38186558)
1. Synchronous Occurrence of Triple-Negative Breast Cancer and Malignant Melanoma.
Taushanova MS; Milusheva YI; Manov DA; Hadjieva RR; Yordanov AD
J Med Cases; 2023 Dec; 14(12):400-404. PubMed ID: 38186558
[TBL] [Abstract][Full Text] [Related]
2. Synchronous and metachronous multiple primary cancers in melanoma survivors: a gender perspective.
Guzzinati S; Buja A; Grotto G; Zorzi M; Manfredi M; Bovo E; Del Fiore P; Tropea S; Dall'Olmo L; Rossi CR; Mocellin S; Rugge M
Front Public Health; 2023; 11():1195458. PubMed ID: 37397750
[TBL] [Abstract][Full Text] [Related]
3. Synchronous occurrence of primary breast cancer and renal cell carcinoma: A case report and literature review.
Rezzoug F; Kharmach I; Derfoufi J; Al Jarroudi O; Brahmi SA; Afqir S
Int J Surg Case Rep; 2024 Jun; 119():109778. PubMed ID: 38762959
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous primary invasive breast carcinoma and ipsilateral cutaneous melanoma of the back: Surgical approach and considerations, a case report.
Fosko NK; Davis CH; Koshenkov VP; Kowzun MJ
Int J Surg Case Rep; 2021 Jul; 84():106155. PubMed ID: 34229213
[TBL] [Abstract][Full Text] [Related]
5. Synchronous and metachronous breast cancer in Ukraine.
Motuzyuk I; Sydorchuk O; Kovtun N; Kostiuchenko Y
Breast Dis; 2017; 37(2):83-93. PubMed ID: 29504518
[TBL] [Abstract][Full Text] [Related]
6. The Rare Diagnosis of Synchronous Breast and Colonic Cancers: A Case Report and Review of Literature.
Asaad A; Barron M; Rasheed N; Idaewor P; Saad Abdalla Al-Zawi A
Cureus; 2021 Feb; 13(2):e13314. PubMed ID: 33738159
[TBL] [Abstract][Full Text] [Related]
7. Triple malignancy involving breast, ovary, and uterine vault: A case report and literature review.
Alam MS; Perween R; Siddiqui SA
J Cancer Res Ther; 2017; 13(6):1059-1061. PubMed ID: 29237978
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of triple primary tumor.
Kurul S; Akgun Z; Saglam EK; Basaran M; Yucel S; Tuzlali S
Int J Surg Case Rep; 2013; 4(11):1013-6. PubMed ID: 24091078
[TBL] [Abstract][Full Text] [Related]
9. Metachronous multiple primary malignant neoplasms of the stomach and the breast: report of two cases with review of literature.
Karthikeyan VS; Sistla SC; Srinivasan R; Basu D; Panicker LC; Ali SM; Rajkumar N
Int Surg; 2014; 99(1):52-5. PubMed ID: 24444270
[TBL] [Abstract][Full Text] [Related]
10. Dual malignancies in the setting of differentiated thyroid carcinoma: their synchronous or metachronous nature, impact of radioiodine treatment on occurrence of second malignancy and other associated variables.
Gandhi S; Abhyankar A; Basu S
Nucl Med Commun; 2014 Feb; 35(2):205-9. PubMed ID: 24217429
[TBL] [Abstract][Full Text] [Related]
11. Synchronous multiple primary malignancies of clear cell renal cell carcinoma with sarcomatoid, thyroid carcinoma: a case report.
Tan Y; Chen X; Ye M; Li X; Liu W; Liao S; Xie Z; Zuo Y
Front Oncol; 2023; 13():1174306. PubMed ID: 37441417
[TBL] [Abstract][Full Text] [Related]
12. Clinical and pathological characteristics of multiple primary malignant neoplasms cases.
Si L; Feng Y; Wang Y; Zhong J; Sun Z; Li X; Sun Y
Int J Clin Pract; 2021 Nov; 75(11):e14663. PubMed ID: 34387916
[TBL] [Abstract][Full Text] [Related]
13. Bilateral synchronous breast cancer developed as metachronous malignancy after therapy of other primaries.
Kurzyński M; Mituś J; Kołodziej-Rzepa M; Sas-Korczyńska B
Ginekol Pol; 2018; 89(5):235-239. PubMed ID: 30084474
[TBL] [Abstract][Full Text] [Related]
14. Metachronous and Synchronous Occurrence of 5 Primary Malignancies in a Female Patient between 1997 and 2013: A Case Report with Germline and Somatic Genetic Analysis.
Nyqvist J; Persson F; Parris TZ; Helou K; Kenne Sarenmalm E; Einbeigi Z; Borg Å; Karlsson P; Kovács A
Case Rep Oncol; 2017; 10(3):1006-1012. PubMed ID: 29279706
[TBL] [Abstract][Full Text] [Related]
15. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
Spanogle JP; Clarke CA; Aroner S; Swetter SM
J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
[TBL] [Abstract][Full Text] [Related]
16. Triple Metachronous Malignancies with Thyroid Involvement: A Brief Overview of Five Case Reports over 20 Years of Institutional Experience.
Bădan MI; Piciu D
Diagnostics (Basel); 2020 Mar; 10(3):. PubMed ID: 32245068
[TBL] [Abstract][Full Text] [Related]
17. Multiple metachronous and synchronous malignancies with lung and thorax involvement. Report of two cases.
Sapalidis K; Schizas N; Lazopoulos A; Kamparoudi P; Paliouras D; Sardeli C; Konstantinou F; Chatzinikolaou F; Sarafis P; Zarogoulidis P; Kougioumtzi I; Katsikogiannis N; Karapantzos I; Karapantzou C; Laskou S; Koulouris C; Mantalobas S; Giannakidis D; Kesisoglou I; Barbetakis N
Respir Med Case Rep; 2018; 24():5-7. PubMed ID: 29977745
[TBL] [Abstract][Full Text] [Related]
18. Impact of FDG PET/CT on detection of synchronous and metachronous malignancies and clinical management in patients with multiple primary cancers.
Ilcheva M; Nikolova P; Hadzhiyska V; Mladenov K
Neoplasma; 2022 Jul; 69(4):948-956. PubMed ID: 35471980
[TBL] [Abstract][Full Text] [Related]
19. Synchronous multiple primary malignant neoplasms in breast, kidney, and bilateral thyroid: A case report.
Jia MM; Yang B; Ding C; Yao YR; Guo J; Yang HB
World J Clin Cases; 2023 Mar; 11(7):1513-1520. PubMed ID: 36926403
[TBL] [Abstract][Full Text] [Related]
20. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial.
Cortes J; Cescon DW; Rugo HS; Nowecki Z; Im SA; Yusof MM; Gallardo C; Lipatov O; Barrios CH; Holgado E; Iwata H; Masuda N; Otero MT; Gokmen E; Loi S; Guo Z; Zhao J; Aktan G; Karantza V; Schmid P;
Lancet; 2020 Dec; 396(10265):1817-1828. PubMed ID: 33278935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
